Immune Cell Infiltration of the Primary Tumor, Not PD-L1 Status, Is Associated With Improved Response to Checkpoint Inhibition in Metastatic Melanoma

Immune checkpoint inhibition has resulted in dramatic improvements in overall and relapse-free survival in patients with metastatic melanoma. The most commonly used immune checkpoint inhibitors are monoclonal antibodies targeting programmed cell death protein 1 and cytotoxic T-lymphocyte-associated...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Christiane Kümpers, Mladen Jokic, Ozan Haase, Anne Offermann, Wenzel Vogel, Victoria Grätz, Ewan A. Langan, Sven Perner, Patrick Terheyden
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Frontiers Media S.A. 2019-03-01
coleção:	Frontiers in Medicine
Assuntos:	melanoma PD-L1 immunoscore checkpoint inhibition lymphocyte metastases
Acesso em linha:	https://www.frontiersin.org/article/10.3389/fmed.2019.00027/full
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!